Literature DB >> 19783725

Uterine adenosarcomas overgrown by sex-cord-like tumour: report of two cases.

S Stolnicu1, K Balachandran, M A Aleykutty, A Loghin, O Preda, E Goez, F F Nogales.   

Abstract

Müllerian adenosarcomas are tumours of low malignant potential with proliferation of benign glands and low grade endometrial stromal sarcoma (LGESS). Unusually, the latter may include foci of uterine tumours resembling ovarian sex-cord tumours (UTROSCT). Two cases of uterine adenosarcomas massively overgrown by UTROSCT are reported, for the first time. The patients, aged 71 and 64, one receiving tamoxifen, presented with intracavitary polypoid adenosarcomas; each was overgrown by an immunopathologically characteristic UTROSCT that constituted more than 75% of its volume. Periglandular CD10+LGESS represented less than 25%. Both are alive and well after 5 and 3 years, respectively. Compared to the poor prognosis of adenosarcomas overgrown by high grade sarcomata, the cases reported here had a benign behaviour. Quantitative assessment of volume percentage of the potentially aggressive LGESS, CD10+ areas should be considered as a relevant prognostic histological parameter in these tumours.

Entities:  

Mesh:

Year:  2009        PMID: 19783725     DOI: 10.1136/jcp.2008.063727

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

1.  The Impact on Survival of an Extensive Sex Cord-like Component in Mullerian Adenosarcomas: A Study Comprising 6 Cases.

Authors:  Simona Stolnicu; Claudiu Molnar; Iulia Barsan; Monica Boros; Francisco F Nogales; Robert A Soslow
Journal:  Int J Gynecol Pathol       Date:  2016-03       Impact factor: 2.762

2.  Post-radiation Mullerian adenosarcoma with sarcomatous overgrowth: rare presentation of an uncommon malignancy.

Authors:  Aysha Mubeen; Mohammad Shahid; Raafat Makary
Journal:  Pathologica       Date:  2020-12

3.  Uterine lesions with sex cord-like architectures: a systematic review.

Authors:  Meng Jia; Ping-Li Sun; Hongwen Gao
Journal:  Diagn Pathol       Date:  2019-11-18       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.